Hyperkalaemia

Cross-source consensus on Hyperkalaemia from 1 sources and 5 claims.

1 sources · 5 claims

Risks & contraindications

Hyperkalaemia can cause life-threatening cardiac arrhythmias. — Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): a randomised controlled trial in the emergency department
Hyperkalaemia is most often seen in patients with diabetes, heart failure, hypertension, chronic kidney disease, or those on renin-angiotensin-aldosterone system inhibitors. — Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): a randomised controlled trial in the emergency department
Hyperkalaemia occurs in up to 3% of emergency department patients and is associated with higher inpatient admission and mortality. — Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): a randomised controlled trial in the emergency department
Urgent hyperkalaemia treatment is not well standardised due to limited trial data and guidelines. — Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): a randomised controlled trial in the emergency department
The prevalence of hyperkalaemia is increasing as chronic kidney disease and related comorbidities become more common. — Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): a randomised controlled trial in the emergency department